IMMX
NASDAQ
$8.80
Immix Biopharma Inc (IMMX)
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology and inflammation in the United States and Australia. The company is headquartered in Los Angeles, California.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $19.75 (+124.43%)
Market Cap
$558M
Free Cash Flow Yield
-5.87%
Beta (5Y)
1.23
Price Chart
Valuation
Market Cap$558M
P/B9.01
Profitability
EBITDA-$54M
EPS-$1.21
Financial Health
Free Cash Flow Yield-5.87%
Growth & Risk
Beta (5Y)1.23
Sharpe Ratio1.67